VWR International LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:VWR International LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013524
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
VWR International LLC (VWR) a subsidiary of VWR Corp is a supplier of products, services and solutions to laboratories. The company’s business areas comprise differentiated services, product choice and operational excellence. Its product choice services include supply of beakers, freezers, biochemicals, reagents and sera among others. VWR also provides custom manufacturing, catalyst laboratory, technology solutions and support to research and laboratory operations. Its technology services include electronic data exchange, file transfer, and apps for electronic devices. The company serves only pharmaceutical, biotechnology, industrial, education, government and healthcare industries. It has its operations in the Americas, Europe, Asia and Africa. VWR is headquartered in Radnor, Pennsylvania, the US.

VWR International LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
VWR International LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
VWR International LLC, Medical Devices Deals, 2011 to YTD 2017 9
VWR International LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
VWR International LLC, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
VWR International Enters Into Distribution Agreement With Thermo Fisher Scientific 11
Debt Offering 12
VWR Completes Private Placement Of Notes Due 2017 For US$750 Million 12
Acquisition 13
VWR International Acquires Reliable Biopharma and BioArra 13
VWR International Acquires Therapak, and Therapak Pharma Services 14
VWR International Acquires National Biochemicals 15
VWR International Acquires LABRepCo 16
VWR International To Acquire Peqlab Biotech 17
VWR International Acquires United Biochemicals 18
VWR International Acquires Prolab Laboratuar Teknolojileri, Scientific Lab Supplies Distributor 19
VWR International Acquires Lab3, Scientific Laboratory Products Distributor 20
VWR International Acquires Sovereign, Laboratory Products Distributor 21
VWR International Acquires INTERNATIONAL P.B.I. 22
VWR International To Acquire LabPartner 23
VWR International Acquires AMRESCO 24
VWR International LLC – Key Competitors 25
VWR International LLC – Key Employees 26
VWR International LLC – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Strategy And Business Planning 29
Aug 22, 2017: VWR Showcases New 125,000 Square Foot Regional Distribution Center 29
Government and Public Interest 30
Mar 13, 2017: The VWR Foundation Advances Science with Over $129,000 in First Quarter Grants 30
Other Significant Developments 31
Jul 20, 2016: SGI-DNA, A Synthetic Genomics Company, Announces Exclusive Global Distribution Agreement for Reagents with VWR 31
Jun 06, 2016: Improving the Customer Experience Through Enhanced Technology 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
VWR International LLC, Pharmaceuticals & Healthcare, Key Facts 2
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
VWR International LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
VWR International LLC, Deals By Therapy Area, 2011 to YTD 2017 8
VWR International LLC, Medical Devices Deals, 2011 to YTD 2017 9
VWR International LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
VWR International Enters Into Distribution Agreement With Thermo Fisher Scientific 11
VWR Completes Private Placement Of Notes Due 2017 For US$750 Million 12
VWR International Acquires Reliable Biopharma and BioArra 13
VWR International Acquires Therapak, and Therapak Pharma Services 14
VWR International Acquires National Biochemicals 15
VWR International Acquires LABRepCo 16
VWR International To Acquire Peqlab Biotech 17
VWR International Acquires United Biochemicals 18
VWR International Acquires Prolab Laboratuar Teknolojileri, Scientific Lab Supplies Distributor 19
VWR International Acquires Lab3, Scientific Laboratory Products Distributor 20
VWR International Acquires Sovereign, Laboratory Products Distributor 21
VWR International Acquires INTERNATIONAL P.B.I. 22
VWR International To Acquire LabPartner 23
VWR International Acquires AMRESCO 24
VWR International LLC, Key Competitors 25
VWR International LLC, Key Employees 26
VWR International LLC, Subsidiaries 27

★海外企業調査レポート[VWR International LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • North Eastern Electric Power Corporation Ltd:電力:M&Aディール及び事業提携情報
    Summary North Eastern Electric Power Corp Ltd (NEEPCO) is a government owned electric utility that generates, procures and sells electricity. The company designs, constructs, operates and maintains hydro, thermal and gas projects. NEEPCO generates electricity from hydro, thermal, and solar sources; …
  • Amedica Corp (AMDA):製品パイプライン分析
    Summary Amedica Corp (Amedica) is a biomaterial company. It develops, manufactures and markets medical-grade silicon nitride ceramics for spinal and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems and others. Amedica also offers n …
  • Secure Energy Services Inc (SES):石油・ガス:M&Aディール及び事業提携情報
    Summary Secure Energy Services Inc. (Secure Energy) is an energy services company. It provides specialized services to upstream oil and natural gas companies operating in the Western Canadian Sedimentary Basin (WCSB) and North Dakota. The company assists these companies with the handling, processing …
  • Strauss Group Ltd.:企業の戦略・SWOT・財務情報
    Strauss Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Strauss Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tampa Electric Co:企業の戦略的SWOT分析
    Tampa Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Panalpina World Transport (Holding) Ltd (PWTN):企業の財務・戦略的SWOT分析
    Panalpina World Transport (Holding) Ltd (PWTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Kerr Corp:企業の戦略的SWOT分析
    Kerr Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • viDA Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary viDA Therapeutics Inc (viDA) is a biopharmaceutical company that discovers, develops and commercializes novel and targeted therapeutics for the treatment of autoimmune and age-related chronic inflammatory diseases. The company’s lead product candidate include VTI-1002, is in a topical formul …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ARC Document Solutions Inc (ARC):企業の財務・戦略的SWOT分析
    Summary ARC Document Solutions Inc (ARC), formerly American Reprographics Company is a provider of technology and document solutions. The company’s services comprise onsite managed print services, construction document and information management, archiving and information management, and sale of web …
  • AGL Energy Ltd (AGL)-石油・ガス分野:企業M&A・提携分析
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Prologis, Inc.:企業のM&A・事業提携・投資動向
    Prologis, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Prologis, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Shutterfly Inc:企業の戦略的SWOT分析
    Shutterfly Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Dermira Inc (DERM)-医療機器分野:企業M&A・提携分析
    Summary Dermira Inc (Dermira) is a bio-pharmaceutical company which concentrates on the development and commercialization of novel therapies for the treatment of chronic skin conditions. The company concentrates on developing drugs for the treatment of diseases such as psoriasis, hyperhidrosis, atop …
  • OriGene Technologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and sells genome research and diagnostic products. OriGene’s products include qPCR reagents, …
  • MEDICREA Group (ALMED):医療機器:M&Aディール及び事業提携情報
    Summary MEDICREA Group (MEDICREA) is a medical equipment company that provides surgical solutions to neurosurgeons and orthopedic surgeons. The company designs, manufactures and distributes proprietary technologies related to patient specific spinal surgery. It offers products such as polyaxial spin …
  • NEC Capital Solutions Ltd. (8793):企業の財務・戦略的SWOT分析
    NEC Capital Solutions Ltd. (8793) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Mereo Biopharma Group Plc (MPH):企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Swietelsky Baugesellschaft mbH:企業の戦略的SWOT分析
    Swietelsky Baugesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Bausch & Lomb Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆